Lisa A. Damico

Randomized Phase II Trial Comparing Bevacizumab Plus Carboplatin and Paclitaxel With Carboplatin and Paclitaxel Alone in Previously Untreated Locally Advanced or Metastatic Non-Small-Cell Lung Cancer

David H. Johnson, Louis Fehrenbacher, William Novotny et al. · Journal of Clinical Oncology · 2004 · 1.9K citations · Full text

Medicine, Oncology, Pharmacology +11

Albumin Binding as a General Strategy for Improving the Pharmacokinetics of Proteins

Mark S. Dennis, Min Zhang, Miryam Kadkhodayan et al. · Journal of Biological Chemistry · 2002 · 498 citations · Full text

Life Sciences, Pharmaceutics, Pharmacokinetics +13

Expression of full-length immunoglobulins in Escherichia coli: rapid and efficient production of aglycosylated antibodies

Laura Simmons, Dorothea Reilly, Laura Klimowski et al. · Journal of Immunological Methods · 2002 · 289 citations

Pharmacy, Microbiology, Molecular Biology +17

PHARMACOKINETICS AND RETINAL DISTRIBUTION OF RANIBIZUMAB, A HUMANIZED ANTIBODY FRAGMENT DIRECTED AGAINST VEGF-A, FOLLOWING INTRAVITREAL ADMINISTRATION IN RABBITS

Jacques Gaudreault, David Fei, Joseph C. Beyer et al. · Retina · 2007 · 187 citations

Medicine, Ophthalmology, Pharmacology +17

The pharmacokinetics of an albumin-binding Fab (AB.Fab) can be modulated as a function of affinity for albumin

Angela Nguyen, A. E. Reyes, M. Zhang et al. · Protein Engineering Design and Selection · 2006 · 141 citations · Full text

Pharmacy, Biochemistry, Pharmacokinetics +15